MedTrace Logo

Estimation of Therapeutic Effect of MDcure on Patients With Chronic Lower Back Pain

NCT02971592 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-01-09

No results posted yet for this study

Summary

This study will assess the therapeutic effect of MDcure® device. MDcure® is an FDA Class 1 listed medical device, produced to ISO-13485 standards, that delivers extremely low intensity (nano Tesla; 10-9) and low frequencies (1-100 Hertz) electromagnetic fields (EMF) intended to reduce muscular aches and pains particularly of the lower back.

assessing the reduction of lower back pain. Half of participants will receive the MDcure device, while the other half will receive a mock device.

Conditions

  • Back Pain Lower Back Chronic

Interventions

DEVICE

MDcure

reception of real working MDcure - device that does apply the electromagnetic field

OTHER

Mock Device

reception of device that does not apply the electromagnetic field

Sponsors & Collaborators

  • Aerotel Ltd

    collaborator INDUSTRY

  • Assuta Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02971592 on ClinicalTrials.gov